IceCure Medical Ltd (ICCM) Stock Analysis

Company Overview

The market values IceCure Medical Ltd (ICCM) at $7.64M. It is classified in the Medical Devices industry, within the Healthcare sector. Headcount on file is 67.

The most recent close on file for ICCM is $2.23, dated September 4, 2026. That is +$0.03 (+1.36%) against the previous close. The 52-week range on file runs from $2.12 to $42.00. The latest close sits 5.19% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $3.38M. That is +2.67% against the prior fiscal year, when revenue was $3.29M. The same year closed with a net loss of $15.06M. The reported profit margin is 0%. That is 1.7 percentage points above the Medical Devices median of −1.69%. Earnings per share on a trailing basis come to −6.78.

Across the 4 fiscal years on file, revenue moves from $3.09M in 2022 to $3.38M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 1.94 times revenue. On price-to-sales that is 34.95% below the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

Over the trailing twelve months the price has returned −92.99%. Across 5 years the annualized return works out at −62.53%. The reported beta is 0.45. Daily returns over the trailing 5 years annualize to a volatility of 155.27%.

Growth & Income

No dividend is on file for ICCM.

The strongest complete calendar year on file is 2024 at +2.80%; the weakest is 2022 at −49.18%. Of the 4 complete calendar years on file, 1 finished higher. So far in 2026 the price is −87.81%.